secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-06-14T23:59:59+00:00
Accession:  0001022079-22-000107
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics names Sam Samad as EVP & CFO, effective July 25, 2022
-----------------------------------------------------------------------

- Samad joins from Illumina (CFO since 2017); start date July 11, CFO role effective July 25.
- Base salary $650k; target annual incentive 90% of base; initial equity grant $2.5M (50% performance shares, 25% options, 25% RSUs).
- Sign-on inducement: cash payment of $1.2M (refundable if voluntary exit within 2 years) and RSUs valued at $1.5M vesting over 2 years.
- Outgoing CFO Mark Guinan remains through Q2 earnings report for transition.
- Samad eligible for executive severance plan, relocation benefits up to $105k, and share ownership guideline of 4x base salary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/0001022079-22-000107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000107/dgx-20220608.htm
  HTML page:      https://secwatch.observer/filing/0001022079-22-000107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer